Dynamic multi-pinhole collimated brain SPECT of Parkinson’s disease by [ 123 I]FP-CIT: a feasibility study of fSPECT

We investigated the feasibility of using a dopamine transporter (DaT) tracer ligand ([ 123 I]FP-CIT) along with novel multi-pinhole brain collimators for dynamic brain single photon emission computed tomography (SPECT) in suspected Parkinson's disease patients. Thirteen patients underwent dynamic tracer acquisitions before standard imaging. Uptake values were corrected for partial volume effects. Specific binding ratio (SBR calc ) was calculated, reflecting binding potential relative to non-displaceable binding (BP ND ) in the cortex. Additional pharmacokinetic parameters (BP ND , R 1 , k 2 ) were estimated using the simplified reference tissue model, revealing differences between Kahraman low-score (LS) and high-score (HS) groups. Results showed increasing striatal tracer uptake until 100 min post-injection, with consistent values afterward. Uptake and SBR calc ratios matched visual assessment. LS patients had lower putamen than caudate nucleus tracer uptake, decreased BP ND values, while R 1 and k 2 values were comparable to HS patients. In conclusion, dynamic multi-pinhole SPECT using DaT tracer with the extraction of pharmacokinetic parameters is feasible and could help enable early differentiation of reduced and normal DaT values.